CPV
DERM

Canaan Partners VII’s Dermira, Inc. DERM Stock Holding History

Canaan Partners VII’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-2,500,149
Closed -$45.3M – 5
2014
Q4 		$45.3M Buy
+2,500,149
New +$41.8M 3.6% 2

Other funds holding DERM

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Canaan Partners VII's DERM Position: Q1 2015 in Review

Canaan Partners VII sold out of Dermira, Inc. (DERM) in Q1 2015, closing a stake of 2,500,149 shares — an estimated $45.3M sold.

Canaan Partners VII first reported a position in DERM in Q4 2014 and held it in 1 quarter. The position peaked at $45.3M in Q4 2014. 53 funds tracked by Wall St. Rank hold DERM as of Q1 2015.

  • Canaan Partners VII reported no remaining Dermira, Inc. position as of Q1 2015 after selling out during the quarter.
  • Canaan Partners VII sold 2,500,149 Dermira, Inc. shares in Q1 2015, an estimated $45.3M.
  • Canaan Partners VII first reported a position in Dermira, Inc. in Q4 2014 and held it in 1 quarter.
  • Canaan Partners VII's Dermira, Inc. position peaked at $45.3M in Q4 2014.
  • 53 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2015.

Based on Canaan Partners VII's 13F filing for Q1 2015, filed 16 Apr 2015.